Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

A painless, contact-free vibration sensor may detect hidden heart and lung problems

NCT ID NCT06661200

Diagnosis Sponsor: University Hospital, Caen Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jul 29, 2026 · Last updated Jul 30, 2026 · Updated 1 time

Summary

This study tests whether a new device that records chest vibrations from a distance can detect heart and lung diseases. Researchers will compare the vibration patterns of people with known cardiac or pulmonary conditions to those of healthy volunteers. If the technique works, it could lead to a quick, low-cost screening tool that requires no special training or patient cooperation.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
a non-invasive thoracic vibration recording device (Surface Camera Motion)
What this could lead to
If successful, this painless, contact-free technique could enable faster, cheaper screening for common heart and lung conditions.
What could go wrong
This is an early exploratory study, so the vibration signatures for each disease are not yet defined. The technique may not prove accurate enough for real-world diagnosis.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

270 people

The number who actually took part.

Started

May 2024

Finished

Aug 2025

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Cardiac disease OR respiratory failure OR healthy volunteer * Affiliate to the social security system * French-speaking * Patient having been informed of the study and having signed informed Exclusion Criteria: * consent.BMI \< 17 or BMI \> 35 * Patients unable to stand for more than 10 minutes * Patients unable to remain in apnea for 15 - 20 seconds * Breast prosthesis wearers * Wearers of pacemakers and/or defibrillators * Valve prosthesis wearers * Patients with difficulty understanding simple instructions (inspiration, expiration, respiratory blockage) * Patients with severe hearing problems. * Pregnant or breastfeeding woman. A urine pregnancy test will be performed if necessary.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Aortic insufficiency are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

aortic valve insufficiency aortic valve stenosis heart disorder lung disorder mitral valve insufficiency pulmonary valve insufficiency respiratory failure

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Aortic insufficiency Aortic stenosis disease Cardiac disease, pulmonary disease Diastolic dysfunction Healthy volunteer Mitral regurgitation Pulmonary insufficiency Systolic dysfunction

Contacts and locations

Locations

  • Caen University Hospital

    Caen, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.